This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ruutu T, Hermans J, van Biezen A, Niederwieser D, Gratwohl A, Apperley JF . How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 22: 614–615.
Bolanos-Meade J, Vogelsang GB . Novel strategies for steroid-refractory acute graft-versus-host disease. Curr Opin Hematol 2005; 12: 40–44.
Couriel D, Caldera H, Champlin R, Komanduri K . Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936–1946.
Bacigalupo A, van Lint MT, Frassoni F, Podesta M, Veneziano G, Avanzi G et al. High dose bolus methylprednisolone for the treatment of acute graft versus host disease. Blut 1983; 46: 125–132.
Deeg HJ . How I treat refractory acute GVHD. Blood 2007, Prepublished online January 18, 2007: doi 10.1182/blood-2006-12-041889.
Knop S, Hebart H, Gscheidle H, Holler E, Kolb HJ, Niederwieser D et al. OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplant 2005; 36: 831–837.
Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, Dallorso S et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006; 107: 4177–4181.
Bruner RJ, Farag SS . Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Semin Oncol 2003; 30: 509–519.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knop, S., Hebart, H., Gratwohl, A. et al. Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia 21, 1830–1833 (2007). https://doi.org/10.1038/sj.leu.2404731
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404731
This article is cited by
-
Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis
Bone Marrow Transplantation (2011)
-
Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD
Bone Marrow Transplantation (2010)